These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2792558)

  • 1. Calcitonin and calcium combined therapy in osteoporosis: effects on vertebra trabecular bone density.
    Ozoran K; Paker N; Başgöze O; Hasçelik Z; Erzen C; Narman S; Ozker R
    J Int Med Res; 1989; 17(4):395-400. PubMed ID: 2792558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increase of axial and appendicular trabecular and cortical bone density in established osteoporosis with intermittent nasal salmon calcitonin therapy.
    Peichl P; Rintelen B; Kumpan W; Bröll H
    Gynecol Endocrinol; 1999 Feb; 13(1):7-14. PubMed ID: 10368793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms underlying the effects of phosphate and calcitonin on bone histology in postmenopausal osteoporosis.
    Marie PJ; Caulin F
    Bone; 1986; 7(1):17-22. PubMed ID: 3964494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of salmon calcitonin on experimental osteoporosis induced by ovariectomy and low-calcium diet in the rat.
    Mochizuki K; Inoue T
    J Bone Miner Metab; 2000; 18(4):194-207. PubMed ID: 10874598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The value of bone scintigraphy in the follow-up of vertebral osteoporosis.
    Rico H; Merono E; Del Olmo J; Revilla M
    Clin Rheumatol; 1991 Sep; 10(3):298-301. PubMed ID: 1790640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcium and salmon calcitonin in treatment of osteoporosis.
    Jowsey J; Riggs BL; Kelly PJ; Hoffman DL
    J Clin Endocrinol Metab; 1978 Sep; 47(3):633-9. PubMed ID: 263316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of calcitonin and vitamin D in osteoporosis.
    Palmieri GM; Pitcock JA; Brown P; Karas JG; Roen LJ
    Calcif Tissue Int; 1989 Sep; 45(3):137-41. PubMed ID: 2505903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of post-menopausal osteoporosis with phosphate and intermittent calcitonin.
    Kuntz D; Marie P; Berhel M; Caulin F
    Int J Clin Pharmacol Res; 1986; 6(2):157-62. PubMed ID: 3522444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Skeletal effects of cyclic recombinant human growth hormone and salmon calcitonin in osteopenic postmenopausal women.
    Holloway L; Kohlmeier L; Kent K; Marcus R
    J Clin Endocrinol Metab; 1997 Apr; 82(4):1111-7. PubMed ID: 9100582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Osteoporosis].
    Bissonnette B
    Union Med Can; 1985 Oct; 114(10):857-64. PubMed ID: 3909576
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of a one-year administration of phosphate and intermittent calcitonin on bone-forming and bone-resorbing cells in involutional osteoporosis: a histomorphometric study.
    Alexandre C; Chappard D; Caulin F; Bertrand A; Palle S; Riffat G
    Calcif Tissue Int; 1988 Jun; 42(6):345-50. PubMed ID: 3135102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of postmenopausal osteoporosis with salmon calcitonin nasal spray: evaluation by bone mineral content and biochemical patterns.
    Tolino A; Romano L; Ronsini S; Riccio S; Montemagno U
    Int J Clin Pharmacol Ther Toxicol; 1993 Jul; 31(7):358-60. PubMed ID: 8370634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term (3 years) prevention of trabecular postmenopausal bone loss with low-dose intermittent nasal salmon calcitonin.
    Reginster JY; Denis D; Deroisy R; Lecart MP; De Longueville M; Zegels B; Sarlet N; Noirfalisse P; Franchimont P
    J Bone Miner Res; 1994 Jan; 9(1):69-73. PubMed ID: 8154311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An evaluation of several biochemical markers for bone formation and resorption in a protocol utilizing cyclical parathyroid hormone and calcitonin therapy for osteoporosis.
    Hodsman AB; Fraher LJ; Ostbye T; Adachi JD; Steer BM
    J Clin Invest; 1993 Mar; 91(3):1138-48. PubMed ID: 8450043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of intranasal salmon calcitonin therapy on bone mineral density in idiopathic male osteoporosis without vertebral fractures--an open label study.
    Tóth E; Csupor E; Mészáros S; Ferencz V; Németh L; McCloskey EV; Horváth C
    Bone; 2005 Jan; 36(1):47-51. PubMed ID: 15664001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of corticosteroid osteoporosis. A comparison of calcium, calcitriol, and calcitonin.
    Sambrook P; Birmingham J; Kelly P; Kempler S; Nguyen T; Pocock N; Eisman J
    N Engl J Med; 1993 Jun; 328(24):1747-52. PubMed ID: 7684512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Calcitonin and bone aging].
    Reginster JY
    Pathol Biol (Paris); 1997 Jan; 45(1):52-6. PubMed ID: 9097847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Salmon calcitonin and calcium in the treatment of male osteoporosis: the effect on bone mineral density.
    Erlacher L; Kettenbach J; Kiener H; Graninger W; Kainberger F; Pietschmann P
    Wien Klin Wochenschr; 1997 Apr; 109(8):270-4. PubMed ID: 9163888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of salmon calcitonin treatment on serum and synovial fluid bone formation and resorption markers in osteoporosis patients.
    Atbinici H; Sipahioğlu S; Aksoy N; Baykara İ; Işıkan UE
    Acta Orthop Traumatol Turc; 2015; 49(2):160-5. PubMed ID: 26012937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcitonins and osteoporosis.
    Gennari C; Agnusdei D
    Br J Clin Pract; 1994; 48(4):196-200. PubMed ID: 7917799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.